Volume 3, Issue 3
Editorialp. 211
Improving cancer clinical trial design and clinical practice: the case for tobacco use in cancer patients
Author(s): Graham W Warren, Erica N Peters
Editorialp. 215
Noninferiority trials: clinical understandings and misunderstandings
Author(s): John H Powers,Thomas R Fleming
Editorialp. 219
Does enrollment in a trial carry a survival advantage for patients?
Author(s): Tal Shahar, Uri Rozovski, Zvi Ram
News and Viewsp. 223
Study suggests that socioeconomic status may affect clinical trial participation
Author(s): Unger JM, Hershman DL, Albain KS
Clinical Trail Prospectivep. 227
Pediatric exclusivity and other contemporary regulatory changes: impact on pediatric drug study, labeling and safety
Author(s): Kevin D Hill, P Brian Smith, Michael Cohen-Wolkowiez, Daniel K Benjamin Jr, Jennifer S Li
Clinical Trail Methodologyp. 241
The handling of missing data in clinical trials
Author(s): Michael G Kenward
Clinical Trail Methodologyp. 251
Quality of life measures in patients on rhinosinusitis trials
Author(s): Eduardo Lehrer-Coriat, Franklin Marino-Sanchez, Isam Alobid, Joaquim Mullol
Review: Clinical Trail Outcomesp. 265
Chemotherapy of advanced non-small-cell lung cancer: current landscape
Author(s): Athanasios G Pallis, Rafal Dziadziuszko & Mary OBrien
Review: Clinical Trail Outcomesp. 281
An update on the management of comorbid conditions in lupus nephritis
Author(s): Vassiliki Tzavara, Cristina Pamfil, Dimitrios T Boumpas, George K Bertsias
Review: Clinical Trail Outcomesp. 295
HIV pre-exposure prophylaxis trials: the road to success
Author(s): Melanie R Nicol, Jessica L Adams, Angela DM Kashuba
Acknowledgementsp. 309
